Ask AI
ProCE Banner Activity

A Roadmap for Managing Refractory CMV

Clinical Thought

Managing refractory cytomegalovirus can be complex, but it doesn’t have to be intimidating. Read on to learn what considerations I account for when formulating a treatment plan. 

Released: July 30, 2025

Share

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE and the American Kidney Fund​

ProCE Banner
ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Partners

American Kidney Fund

ProCE Banner

Disclosure

Primary Author

Marcus Pereira, MD, MPH, FAST: consultant/advisor/speaker: Kamada, Synklino.